Literature DB >> 8759734

Enhanced generation of NK cells with intact cytotoxic function in CD45 exon 6-deficient mice.

H Yamada1, K Kishihara, Y Y Kong, K Nomoto.   

Abstract

CD45 is a cell membrane-type protein tyrosine phosphatase that is essential for Ag receptor-mediated signaling in both T and B lymphocytes. To characterize roles of CD45 molecules in murine NK cells, we analyzed the development and the cytotoxic functions of NK cells in mice lacking CD45 exon 6 (CD45 -/-). A markedly increased number of NK cells was observed in spleens of the CD45 -/- mice, despite no CD45 surface expression on the NK cells. From the results of mixed bone marrow chimera experiments, it was demonstrated that the expansion of NK cells in CD45 -/- mice was due to the influence of disappeared expression of CD45 in the NK cells per se, but not to the modulation of environmental factors. The NK cells in the CD45 -/- mice had normal cytotoxic activities, including NK and Ab-dependent cell-mediated cytotoxicity activities comparable with those in normal mice (CD45 +/+). Additionally, the CD45 -/- NK cells could functionally differentiate to lymphokine-activated killer cells by culturing with a high dose of IL-2, despite a lack of induced expression of B220. Therefore, these results suggest that CD45 is involved in NK cell development, but is not essential for cytotoxic activities and Fc gamma R-mediated signaling in NK cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8759734

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Current perspectives of natural killer cell education by MHC class I molecules.

Authors:  Petter Höglund; Petter Brodin
Journal:  Nat Rev Immunol       Date:  2010-09-06       Impact factor: 53.106

2.  Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production.

Authors:  David G T Hesslein; Rayna Takaki; Michelle L Hermiston; Arthur Weiss; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-20       Impact factor: 11.205

3.  Participation of CD45, NKR-P1A and ANK61 antigen in rat hepatic NK cell (pit cell)mediated target cell cytotoxicity.

Authors:  Dian-Zhong Luo; David Vermijlen; B lent Ahishali; Vasilis Triantis; Karin Vanderkerken; Peter JK Kuppen Kuppen; Eddie Wisse
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

4.  Immune cell inhibition by SLAMF7 is mediated by a mechanism requiring src kinases, CD45, and SHIP-1 that is defective in multiple myeloma cells.

Authors:  Huaijian Guo; Mario-Ernesto Cruz-Munoz; Ning Wu; Michael Robbins; André Veillette
Journal:  Mol Cell Biol       Date:  2014-10-13       Impact factor: 4.272

5.  Differential requirements for CD45 in NK-cell function reveal distinct roles for Syk-family kinases.

Authors:  David G T Hesslein; Emil H Palacios; Joseph C Sun; Joshua N Beilke; Susan R Watson; Arthur Weiss; Lewis L Lanier
Journal:  Blood       Date:  2011-01-18       Impact factor: 22.113

Review 6.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.

Authors:  Michelle L Hermiston; Julie Zikherman; Jing W Zhu
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

7.  Bovine CD2-/NKp46+ cells are fully functional natural killer cells with a high activation status.

Authors:  Preben Boysen; Ingrid Olsen; Ingvild Berg; Siri Kulberg; Grethe M Johansen; Anne K Storset
Journal:  BMC Immunol       Date:  2006-04-27       Impact factor: 3.615

8.  A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells.

Authors:  Nicholas D Huntington; Yuekang Xu; Stephen L Nutt; David M Tarlinton
Journal:  J Exp Med       Date:  2005-05-02       Impact factor: 14.307

9.  Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection.

Authors:  Seung-Hwan Lee; Kwang-Sin Kim; Nassima Fodil-Cornu; Silvia M Vidal; Christine A Biron
Journal:  J Exp Med       Date:  2009-08-31       Impact factor: 14.307

10.  Enhanced antitumor immunity in mice deficient in CD69.

Authors:  Enric Esplugues; David Sancho; Javier Vega-Ramos; Carlos Martínez; Uta Syrbe; Alf Hamann; Pablo Engel; Francisco Sánchez-Madrid; Pilar Lauzurica
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.